Search
for
Sort by
Research 30 of 1000+
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Emerging pharmacotherapies for Androgenetic Alopecia
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Updates in Treatment for Androgenetic Alopecia
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Beyond Minoxidil: Off-Label Therapies for Male Androgenetic Alopecia—A Systematic Review with Network Meta-Analyses
- Recent Advances in Drug Development for Hair Loss
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- 1116 Novel androgen receptor degrader for androgenetic alopecia (AGA) application
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
- 52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia (AGA)
- ISID1116 – Novel androgen receptor degrader for androgenetic alopecia (AGA) application
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Therapeutic Strategies to Target the Androgen Receptor
- Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic Alopecia
- A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex
- The Progress of Common Treatments and Research for Androgenetic Alopecia
- Structural Characterization and Ligand Specific Protein Interactions of Androgen Receptor
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Sebocytes are the Key Regulators of Androgen Homeostasis in Human Skin
- ADVANCEMENTS IN TREATMENT STRATEGIES FOR ANDROGENETIC ALOPECIA: NOVEL THERAPIES AND FUTURE PERSPECTIVES
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Androgen Receptor Ligands: Agonists and Antagonists
- Androgen receptor: A promising therapeutic target in breast cancer
- The role of androgen and androgen receptor in skin-related disorders